Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms - PubMed (original) (raw)
Comparative Study
Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms
Mostafa Bentahir et al. J Neurochem. 2006 Feb.
Free article
Abstract
Mutations in human presenilin (PS) genes cause aggressive forms of familial Alzheimer's disease. Presenilins are polytopic proteins that harbour the catalytic site of the gamma-secretase complex and cleave many type I transmembrane proteins including beta-amyloid precursor protein (APP), Notch and syndecan 3. Contradictory results have been published concerning whether PS mutations cause 'abnormal' gain or (partial) loss of function of gamma-secretase. To avoid the possibility that wild-type PS confounds the interpretation of the results, we used presenilin-deficient cells to analyse the effects of different clinical mutations on APP, Notch, syndecan 3 and N-cadherin substrate processing, and on gamma-secretase complex formation. A loss in APP and Notch substrate processing at epsilon and S3 cleavage sites was observed with all presenilin mutants, whereas APP processing at the gamma site was affected in variable ways. PS1-Delta9 and PS1-L166P mutations caused a reduction in beta-amyloid peptide Abeta40 production whereas PS1-G384A mutant significantly increased Abeta42. Interestingly PS2, a close homologue of PS1, appeared to be a less efficient producer of Abeta than PS1. Finally, subtle differences in gamma-secretase complex assembly were observed. Overall, our results indicate that the different mutations in PS affect gamma-secretase structure or function in multiple ways.
Similar articles
- Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W, Zhang J, Ostaszewski BL, Kimberly WT, Seubert P, Koo EH, Shen J, Selkoe DJ. Xia W, et al. Biochemistry. 1998 Nov 24;37(47):16465-71. doi: 10.1021/bi9816195. Biochemistry. 1998. PMID: 9843412 - Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane.
Kaether C, Lammich S, Edbauer D, Ertl M, Rietdorf J, Capell A, Steiner H, Haass C. Kaether C, et al. J Cell Biol. 2002 Aug 5;158(3):551-61. doi: 10.1083/jcb.200201123. Epub 2002 Jul 29. J Cell Biol. 2002. PMID: 12147673 Free PMC article. - Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC, Hudson M, Kanning KC, Schecterson LC, Bothwell M. Wiley JC, et al. J Neurochem. 2005 Sep;94(5):1189-201. doi: 10.1111/j.1471-4159.2005.03266.x. Epub 2005 Jun 30. J Neurochem. 2005. PMID: 15992373 - [Beta-amyloid protein: recent progress in basic research and therapeutic approaches].
Iwatsubo T. Iwatsubo T. Rinsho Shinkeigaku. 2001 Dec;41(12):1198-200. Rinsho Shinkeigaku. 2001. PMID: 12235837 Review. Japanese. - Presenilin function and gamma-secretase activity.
Brunkan AL, Goate AM. Brunkan AL, et al. J Neurochem. 2005 May;93(4):769-92. doi: 10.1111/j.1471-4159.2005.03099.x. J Neurochem. 2005. PMID: 15857382 Review.
Cited by
- Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production.
Arafi P, Devkota S, Maesako M, Wolfe MS. Arafi P, et al. bioRxiv [Preprint]. 2024 Aug 31:2024.08.30.610520. doi: 10.1101/2024.08.30.610520. bioRxiv. 2024. PMID: 39257787 Free PMC article. Preprint. - An expeditious and facile method of amyloid beta (1-42) purification.
Haque MA, Park IS. Haque MA, et al. PLoS One. 2024 Jul 11;19(7):e0307213. doi: 10.1371/journal.pone.0307213. eCollection 2024. PLoS One. 2024. PMID: 38990960 Free PMC article. - Apo and Aβ46-bound γ-secretase structures provide insights into amyloid-β processing by the APH-1B isoform.
Odorčić I, Hamed MB, Lismont S, Chávez-Gutiérrez L, Efremov RG. Odorčić I, et al. Nat Commun. 2024 May 27;15(1):4479. doi: 10.1038/s41467-024-48776-2. Nat Commun. 2024. PMID: 38802343 Free PMC article. - Familial Alzheimer mutations stabilize synaptotoxic γ-secretase-substrate complexes.
Devkota S, Zhou R, Nagarajan V, Maesako M, Do H, Noorani A, Overmeyer C, Bhattarai S, Douglas JT, Saraf A, Miao Y, Ackley BD, Shi Y, Wolfe MS. Devkota S, et al. Cell Rep. 2024 Feb 27;43(2):113761. doi: 10.1016/j.celrep.2024.113761. Epub 2024 Feb 13. Cell Rep. 2024. PMID: 38349793 Free PMC article. - Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives.
Bhole RP, Chikhale RV, Rathi KM. Bhole RP, et al. IBRO Neurosci Rep. 2023 Nov 30;16:8-42. doi: 10.1016/j.ibneur.2023.11.003. eCollection 2024 Jun. IBRO Neurosci Rep. 2023. PMID: 38169888 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials